| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.011 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |